Cargando…

Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy

Independent of tumor type and non‐invasive or minimally‐invasive feature, current physical treatments including ultrasound therapy, microwave ablation (MWA), and radiofrequency ablation (RFA) are widely used as the local treatment methods in clinics for directly killing tumors and activating systema...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qiaoqiao, Zhang, Wei, Jiao, Rong, Lv, Zheng, Lin, Xia, Xiao, Yunping, Zhang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561875/
https://www.ncbi.nlm.nih.gov/pubmed/36002305
http://dx.doi.org/10.1002/advs.202203921
_version_ 1784808043708416000
author Liu, Qiaoqiao
Zhang, Wei
Jiao, Rong
Lv, Zheng
Lin, Xia
Xiao, Yunping
Zhang, Kun
author_facet Liu, Qiaoqiao
Zhang, Wei
Jiao, Rong
Lv, Zheng
Lin, Xia
Xiao, Yunping
Zhang, Kun
author_sort Liu, Qiaoqiao
collection PubMed
description Independent of tumor type and non‐invasive or minimally‐invasive feature, current physical treatments including ultrasound therapy, microwave ablation (MWA), and radiofrequency ablation (RFA) are widely used as the local treatment methods in clinics for directly killing tumors and activating systematic immune responses. However, the activated immune responses are inadequate and incompetent for tumor recession, and the incomplete thermal ablation even aggravates the immunosuppressive tumor microenvironment (ITM), resulting in the intractable tumor recurrence and metastasis. Intriguingly, nanomedicine provides a powerful platform as they can elevate energy utilization efficiency and augment oncolytic effects for mitigating ITM and potentiating the systematic immune responses. Especially after combining with clinical immunotherapy, the anti‐tumor killing effect by activating or enhancing the human anti‐tumor immune system is reached, enabling the effective prevention against tumor recurrence and metastasis. This review systematically introduces the cutting‐edge progress and direction of nanobiotechnologies and their corresponding nanomaterials. Moreover, the enhanced physical treatment efficiency against tumor progression, relapse, and metastasis via activating or potentiating the autologous immunity or combining with exogenous immunotherapeutic agents is exemplified, and their rationales are analyzed. This review offers general guidance or directions to enhance clinical physical treatment from the perspectives of immunity activation or magnification.
format Online
Article
Text
id pubmed-9561875
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95618752022-10-16 Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy Liu, Qiaoqiao Zhang, Wei Jiao, Rong Lv, Zheng Lin, Xia Xiao, Yunping Zhang, Kun Adv Sci (Weinh) Reviews Independent of tumor type and non‐invasive or minimally‐invasive feature, current physical treatments including ultrasound therapy, microwave ablation (MWA), and radiofrequency ablation (RFA) are widely used as the local treatment methods in clinics for directly killing tumors and activating systematic immune responses. However, the activated immune responses are inadequate and incompetent for tumor recession, and the incomplete thermal ablation even aggravates the immunosuppressive tumor microenvironment (ITM), resulting in the intractable tumor recurrence and metastasis. Intriguingly, nanomedicine provides a powerful platform as they can elevate energy utilization efficiency and augment oncolytic effects for mitigating ITM and potentiating the systematic immune responses. Especially after combining with clinical immunotherapy, the anti‐tumor killing effect by activating or enhancing the human anti‐tumor immune system is reached, enabling the effective prevention against tumor recurrence and metastasis. This review systematically introduces the cutting‐edge progress and direction of nanobiotechnologies and their corresponding nanomaterials. Moreover, the enhanced physical treatment efficiency against tumor progression, relapse, and metastasis via activating or potentiating the autologous immunity or combining with exogenous immunotherapeutic agents is exemplified, and their rationales are analyzed. This review offers general guidance or directions to enhance clinical physical treatment from the perspectives of immunity activation or magnification. John Wiley and Sons Inc. 2022-08-24 /pmc/articles/PMC9561875/ /pubmed/36002305 http://dx.doi.org/10.1002/advs.202203921 Text en © 2022 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Liu, Qiaoqiao
Zhang, Wei
Jiao, Rong
Lv, Zheng
Lin, Xia
Xiao, Yunping
Zhang, Kun
Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy
title Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy
title_full Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy
title_fullStr Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy
title_full_unstemmed Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy
title_short Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy
title_sort rational nanomedicine design enhances clinically physical treatment‐inspired or combined immunotherapy
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561875/
https://www.ncbi.nlm.nih.gov/pubmed/36002305
http://dx.doi.org/10.1002/advs.202203921
work_keys_str_mv AT liuqiaoqiao rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy
AT zhangwei rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy
AT jiaorong rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy
AT lvzheng rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy
AT linxia rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy
AT xiaoyunping rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy
AT zhangkun rationalnanomedicinedesignenhancesclinicallyphysicaltreatmentinspiredorcombinedimmunotherapy